• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Vertex Pharmaceuticals

Vertex Pharmaceuticals

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. UPDATE: Bull trend intact despite oil-related -2-

    UPDATE: Bull trend intact despite oil-related -2-

  2. UPDATE: Bull trend intact despite oil-related -5-

    UPDATE: Bull trend intact despite oil-related -5-

  3. UPDATE: Bull trend intact despite oil-related -4-

    UPDATE: Bull trend intact despite oil-related -4-

  4. UPDATE: Bull trend intact despite oil-related -3-

    UPDATE: Bull trend intact despite oil-related -3-

  5. Market bears fire shot across the bow -2-

    Market bears fire shot across the bow -2-

  6. UPDATE: Bull trend intact despite oil-related cross currents

    UPDATE: Bull trend intact despite oil-related cross currents

  7. Research and Markets: Migraine - Pipeline Review, H2 2014

    Research and Markets: Migraine - Pipeline Review, H2 2014

  8. A Favorable Prognosis for This Pharma Stock

    Recent clinical success in cystic fibrosis positions Vertex as a dominant player in this attractive rare-disease market.

  9. Reinvent Your Practice: Alternatives to Traditional Succession Planning

    Following is a roundup of stocks that recently jumped to 5 stars in the last week. By way of background, we award a stock 5 stars when it trades at a suitably large discount--i.e., a margin of safety--to our fair value estimate. Thus, when a stock hits 5-star territory, we consider it an especially ...

  10. Gilead Sciences Carving Out a Wider Moat

    StockInvestor editor Matt Coffina and senior biotech analyst Karen Andersen discuss Gilead's growing competitive advantages.

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.